Polin Helene, Danzer Martin, Gaszner Waltraud, Broda Doris, St-Louis Maryse, Pröll Johannes, Hofer Katja, Gabriel Christian
Red Cross Transfusion Service of Upper Austria, Krankenhausstrasse 7, Linz, Austria.
Transfusion. 2009 Apr;49(4):676-81. doi: 10.1111/j.1537-2995.2008.02046.x. Epub 2009 Jan 2.
Aberrant RHD alleles leading to a reduced expression of D antigen on the red blood cell (RBC) surface may be mistyped as D- by serology. To quantify the occurrence of weak D, DEL, and D+/- chimera among apparent D- first-time blood donors, polymerase chain reaction (PCR) screening was implemented as a routine service.
A total of 23,330 pretyped D- samples were tested for RHD markers in Exons 4, 7, and 10 in pools of 20 by PCR. Samples with positive results in PCR were reevaluated by exon-specific PCRs, DNA sequencing, and serologic methods.
Among 94 PCR-positive samples, 74 exhibited a weak D or DEL phenotype, dubbed weak D type 1, weak D type 2, weak D type 5, weak D type 32, weak D type 4.3, RHD(M295I), RHD(del147), and RHD(1227G>A). The most prevalent alleles were weak D type 4.3 (n = 31) and RHD(IVS3+1G>A) (n = 24).
As a clinical consequence, 74 blood donor samples carrying weak D and DEL phenotypes with the potential of causing secondary immunizations in recipients were reclassified as D+. Those samples were reliably amplified by RHD Exon 7 PCR; therefore, its usage in the Upper Austrian population is recommended. The association of the weak D type 4.3 samples with a ce leads to the policy that all apparently D- donors should be tested with genotyping methods; otherwise, potentially immunogenic RHD alleles may be overseen.
导致红细胞(RBC)表面D抗原表达降低的异常RHD等位基因可能在血清学检测中被误判为D阴性。为了量化初次献血者中弱D、DEL和D +/-嵌合体的发生率,聚合酶链反应(PCR)筛查已作为一项常规服务开展。
通过PCR对总共23330份预先分型为D阴性的样本进行检测,以20份样本为一组检测第4、7和10外显子中的RHD标记。PCR检测结果呈阳性的样本通过外显子特异性PCR、DNA测序和血清学方法进行重新评估。
在94份PCR阳性样本中,74份表现出弱D或DEL表型,分别为弱D 1型、弱D 2型、弱D 5型、弱D 32型、弱D 4.3型、RHD(M295I)、RHD(del147)和RHD(1227G>A)。最常见的等位基因是弱D 4.3型(n = 31)和RHD(IVS3 + 1G>A)(n = 24)。
临床上,74份携带弱D和DEL表型、有可能在受血者中引起二次免疫的献血者样本被重新分类为D阳性。这些样本通过RHD第7外显子PCR能够可靠地扩增;因此,建议在上奥地利人群中使用该方法。弱D 4.3型样本与ce的关联导致一项政策,即所有表面上为D阴性的献血者都应采用基因分型方法进行检测;否则,可能会遗漏潜在的免疫原性RHD等位基因。